Switch-Maintenance Therapy With Nivolumab In Tki-Sensitive Patients With Metastatic Renal Cell Carcinoma (Mrcc): Subgroup Analysis For Pd-L1 Status Of A Randomized Phase II Study (Nivoswitch)
Nivolumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Switch-Maintenance Therapy With Nivolumab In Tki-Sensitive Patients With Metastatic Renal Cell Carcinoma (Mrcc): Subgroup Analysis For Pd-L1 Status Of A Randomized Phase II Study (Nivoswitch) ### Output: Nivolumab